AnGes, Inc. (TYO:4563)
Japan · Delayed Price · Currency is JPY 52.00
0.00 (0.00%)
May 12, 2026, 3:30 PM JST
AnGes Market Cap
AnGes has a market cap or net worth of 20.61 billion as of May 12, 2026. Its market cap has increased by 3.30% in one year.
Market Cap
20.61B
Enterprise Value
20.46B
Revenue
908.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
52.00
Market Cap Chart
Since September 25, 2002, AnGes's market cap has decreased from 23.36B to 20.61B, a decrease of -11.78%. That is a compound annual growth rate of -0.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 20.61B | -12.82% |
| Dec 30, 2025 | 23.64B | 57.68% |
| Dec 30, 2024 | 14.99B | 5.37% |
| Dec 29, 2023 | 14.23B | -31.96% |
| Dec 30, 2022 | 20.91B | -64.42% |
| Dec 30, 2021 | 58.78B | -64.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Japan Tissue Engineering | 23.88B |
| RaQualia Pharma | 20.69B |
| StemRIM | 18.80B |
| Stella Pharma | 18.57B |
| Renascience | 17.33B |
| ReproCELL | 16.54B |
| CanBas | 13.05B |
| Immuno-Biological Laboratories | 13.00B |